Syensqo (SYENS) Q4 2024 earnings summary

Executive summary

• Achieved 2% organic net sales growth in Q4 2024, with full-year net sales of €6.6 billion and underlying EBITDA of €1.4 billion, led by technology solutions, Novecare, and Composite Materials, despite macroeconomic softness and pricing headwinds.

• Operated with increased agility post-spin-off, focusing on capital allocation, innovation, and shareholder returns, including a €300 million share buyback program and a proposed €1.62 per share dividend.

• Strategic initiatives included divestment plans for Oil & Gas and Aroma businesses, digital transformation, and exploration of a potential dual U.S. listing.

• Americas region remains a strategic focus, representing 41% of sales and housing over half of industrial sites.

Financial highlights

• Q4 2024 net sales were €1.6 billion (+2% YoY organic), with gross profit of €482 million (30.2% margin) and underlying EBITDA of €298 million (+5% YoY organic).

• FY 2024 net sales were €6.6 billion (-4% YoY), underlying EBITDA €1.4 billion (21.5% margin), and underlying net profit €553 million.

• Free cash flow for 2024 was €390 million (excluding €167 million NJDEP payment), with operating cash flows of €841 million.

• Net debt at year-end was €1.86 billion, with a leverage ratio of 1.3x and gearing ratio of 21%.

• Underlying EPS for 2024 was €5.28, down 26% year-over-year.

Outlook and guidance

• 2025 guidance sets underlying EBITDA at a floor of €1.4 billion, capex at ~€600 million, and free cash flow at ~€400 million.

• Cost savings and efficiency initiatives target over €200 million run-rate by end of 2026, with Q1 2025 EBITDA expected to be the lowest quarter.

• Volumes expected to be flat in 2025, with muted demand recovery and continued macroeconomic uncertainty.